Integrative Biology · 2015 · 40 citations · 33 references
Life SciencesBioengineeringPhysiologyCell SignalingDiabetologyDrug DeliveryDiabetes MellitusHormone SecretionHormone StorageInsulin TherapyPancreatic HormonesPeptide DeliveryDiabetes-related ComplicationsEndocrine Cell Secretory GranulesInsulin Delivery DevicesInsulin StoragePancreatic Beta-cell SecretionPancreatic Islet CellsPancreatic Peptide HormonesPeptide Hormone Secretion
People with type 1 diabetes (T1D) must administer insulin exogenously due to the destruction of their pancreatic β-cells. Endogenous insulin is stored in β-cell granules along with C-peptide, a 31 amino acid peptide that is secreted from these granules in amounts equal to insulin. Exogenous co-administration of C-peptide with insulin has proven to reduce diabetes-associated complications in animals and humans. The exact mechanism of C-peptide's beneficial effects after secretion from the β-cell granules is not completely understood, thus hindering its development as an exogenously administered hormone. Monitoring tissue-to-tissue communication using a 3D-printed microfluidic device revealed that zinc and C-peptide are being delivered to erythrocytes by albumin. Upon delivery, erythrocyte-derived ATP increased by >50%, as did endothelium-derived NO, which was measured downstream in the 3D-printed device. Our results suggest that hormone replacement therapy in diabetes may be improved by exogenous administration of a C-peptide ensemble that includes zinc and albumin.
33
Microvascular and Macrovascular Complications of Diabetes
Michael J. Fowler · Clinical Diabetes · 2008 · 1.9K citations
Eric A. Pierce, Robert L. Avery, E D Foley et al. · Proceedings of the National Academy of Sciences · 1995 · 1K citations · Full text